The global market for Stem Cell Banking is estimated at US$9.3 Billion in 2023 and is projected to reach US$15.6 Billion by 2030, growing at a CAGR of 7.5% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the stem cell banking market is driven by several factors, including increased public awareness and understanding of the potential therapeutic uses of stem cells, advancements in biomedical technologies, and the global rise in chronic diseases and genetic disorders. The market is further propelled by the growing number of births in developing countries, where parents are increasingly opting to store their newborns' stem cells in light of improving economic conditions and healthcare infrastructures. Consumer behavior is also influenced by intense marketing campaigns and partnerships between hospitals and private banks, which help educate expecting parents about the benefits of stem cell storage.
Additionally, the ongoing development of more sophisticated and targeted therapies in the field of personalized medicine necessitates a reliable supply of stem cells, thus ensuring continued demand for banking services. These drivers, along with supportive governmental health policies and a growing trend towards preventive healthcare measures, indicate a promising growth trajectory for the stem cell banking industry.
The growth in the stem cell banking market is driven by several factors, including increased public awareness and understanding of the potential therapeutic uses of stem cells, advancements in biomedical technologies, and the global rise in chronic diseases and genetic disorders. The market is further propelled by the growing number of births in developing countries, where parents are increasingly opting to store their newborns' stem cells in light of improving economic conditions and healthcare infrastructures. Consumer behavior is also influenced by intense marketing campaigns and partnerships between hospitals and private banks, which help educate expecting parents about the benefits of stem cell storage.
Additionally, the ongoing development of more sophisticated and targeted therapies in the field of personalized medicine necessitates a reliable supply of stem cells, thus ensuring continued demand for banking services. These drivers, along with supportive governmental health policies and a growing trend towards preventive healthcare measures, indicate a promising growth trajectory for the stem cell banking industry.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Placental and Cord Blood Stem Cells Source segment, which is expected to reach US$10.5 Billion by 2030 with a CAGR of a 8.2%. The Adipose Tissue-Derived Stem Cells (ADSCS) Source segment is also set to grow at 7.0% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $3.6 Billion in 2023, and China, forecasted to grow at an impressive 9.9% CAGR to reach $2.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Stem Cell Banking Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Stem Cell Banking Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Stem Cell Banking Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as FUJIFILM Holdings Corporation, Reliance Life Sciences, Cellavision AB, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 78 Featured):
- FUJIFILM Holdings Corporation
- Reliance Life Sciences
- Cellavision AB
- Cryo-Cell International, Inc.
- Stem Cell Medicine Ltd.
- LifebankUSA
- LifeCell International Pvt., Ltd.
- CBR Systems, Inc.
- Medipost Co., Ltd.
- New England Cord Blood Bank, Inc.
- New York Blood Center
- Pharmicell Co., Ltd.
- CellResearch Corporation Pte., Ltd.
- AlphaCard
- FUJIFILM Cellular Dynamics, Inc.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARYIII. MARKET ANALYSISCANADAITALYREST OF EUROPEREST OF WORLDIV. COMPETITION
1. MARKET OVERVIEW
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
Companies Mentioned
- FUJIFILM Holdings Corporation
- Reliance Life Sciences
- Cellavision AB
- Cryo-Cell International, Inc.
- Stem Cell Medicine Ltd.
- LifebankUSA
- LifeCell International Pvt., Ltd.
- CBR Systems, Inc.
- Medipost Co., Ltd.
- New England Cord Blood Bank, Inc.
- New York Blood Center
- Pharmicell Co., Ltd.
- CellResearch Corporation Pte., Ltd.
- AlphaCard
- FUJIFILM Cellular Dynamics, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 289 |
| Published | November 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 9.3 Billion |
| Forecasted Market Value ( USD | $ 15.6 Billion |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
